Revance Research Development vs Ebitda Analysis

RVNC Stock

USD 3.73 0.11 2.86%

Revance financial indicator trend analysis is much more than just breaking down Revance prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Revance is a good investment. Please check the relationship between Revance Research Development and its Ebitda accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Revance. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For information on how to trade Revance Stock refer to our How to Trade Revance Stock guide.

Research Development vs Ebitda

Research Development vs Ebitda Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Revance Research Development account and Ebitda. At this time, the significance of the direction appears to have pay attention.

The correlation between Revance's Research Development and Ebitda is -0.84. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Ebitda in the same time period over historical financial statements of Revance, assuming nothing else is changed. The correlation between historical values of Revance's Research Development and Ebitda is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Revance are associated (or correlated) with its Ebitda. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebitda has no effect on the direction of Research Development i.e., Revance's Research Development and Ebitda go up and down completely randomly.

Correlation Coefficient

-0.84

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Research Development

Ebitda

Most indicators from Revance's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Revance current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Revance. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For information on how to trade Revance Stock refer to our How to Trade Revance Stock guide.At present, Revance's Tax Provision is projected to decrease significantly based on the last few years of reporting. The current year's Issuance Of Capital Stock is expected to grow to about 124.1 M, whereas Sales General And Administrative To Revenue is forecasted to decline to 0.16.

	2021	2022	2023	2024 (projected)
Interest Expense	6.3M	16.5M	19.4M	20.3M
Depreciation And Amortization	19.9M	33.7M	13.7M	8.0M

Interest Expense Depreciation And Amortization

Revance fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt
Total Assets		0.6	0.64	0.33	0.49	0.74	0.71	0.59	0.22	-0.76	0.75	0.69	0.88	0.53	0.5	0.65	0.92	0.81	0.74	0.55	0.77	0.86	0.54	0.71	0.94	-0.34
Short Long Term Debt Total	0.6		0.95	0.6	-0.35	0.89	0.93	0.29	0.88	-0.93	0.5	0.08	0.68	0.95	0.95	0.93	0.37	0.88	0.56	0.98	0.75	0.82	0.98	0.93	0.45	0.01
Other Current Liab	0.64	0.95		0.67	-0.29	0.87	0.94	0.27	0.82	-0.92	0.57	0.12	0.71	0.91	0.9	0.91	0.42	0.89	0.62	0.94	0.76	0.83	0.95	0.94	0.49	0.04
Total Current Liabilities	0.33	0.6	0.67		-0.35	0.46	0.49	0.27	0.6	-0.52	0.42	-0.11	0.48	0.5	0.48	0.48	0.1	0.45	0.35	0.54	0.45	0.39	0.63	0.49	0.18	0.7
Total Stockholder Equity	0.49	-0.35	-0.29	-0.35		-0.1	-0.13	0.48	-0.7	0.07	0.29	0.78	0.19	-0.35	-0.37	-0.22	0.72	0.05	0.24	-0.43	0.1	0.18	-0.45	-0.13	0.64	-0.46
Other Liab	0.74	0.89	0.87	0.46	-0.1		0.91	0.35	0.7	-0.93	0.69	0.24	0.76	0.82	0.81	0.96	0.54	0.91	0.68	0.89	0.89	0.89	0.88	0.91	0.62	-0.19
Property Plant And Equipment Net	0.71	0.93	0.94	0.49	-0.13	0.91		0.39	0.73	-0.97	0.65	0.26	0.7	0.9	0.91	0.94	0.53	0.96	0.63	0.9	0.85	0.92	0.9	1.0	0.61	-0.17
Current Deferred Revenue	0.59	0.29	0.27	0.27	0.48	0.35	0.39		0.02	-0.53	0.61	0.48	0.33	0.28	0.3	0.36	0.66	0.57	0.55	0.14	0.51	0.64	0.17	0.39	0.69	-0.12
Net Debt	0.22	0.88	0.82	0.6	-0.7	0.7	0.73	0.02		-0.71	0.21	-0.4	0.44	0.86	0.85	0.79	-0.07	0.62	0.43	0.9	0.5	0.52	0.91	0.73	0.03	0.21
Retained Earnings	-0.76	-0.93	-0.92	-0.52	0.07	-0.93	-0.97	-0.53	-0.71		-0.7	-0.29	-0.7	-0.92	-0.92	-0.96	-0.61	-0.99	-0.72	-0.88	-0.84	-0.96	-0.88	-0.97	-0.69	0.17
Accounts Payable	0.75	0.5	0.57	0.42	0.29	0.69	0.65	0.61	0.21	-0.7		0.51	0.66	0.41	0.44	0.6	0.64	0.75	0.47	0.46	0.85	0.75	0.48	0.65	0.7	-0.19
Cash	0.69	0.08	0.12	-0.11	0.78	0.24	0.26	0.48	-0.4	-0.29	0.51		0.39	0.03	0.04	0.12	0.85	0.38	0.17	0.01	0.39	0.49	-0.01	0.26	0.8	-0.42
Non Current Assets Total	0.88	0.68	0.71	0.48	0.19	0.76	0.7	0.33	0.44	-0.7	0.66	0.39		0.53	0.48	0.64	0.63	0.72	0.63	0.68	0.8	0.72	0.68	0.7	0.66	-0.14
Non Currrent Assets Other	0.53	0.95	0.91	0.5	-0.35	0.82	0.9	0.28	0.86	-0.92	0.41	0.03	0.53		0.99	0.92	0.36	0.86	0.62	0.92	0.61	0.81	0.92	0.9	0.45	-0.08
Other Assets	0.5	0.95	0.9	0.48	-0.37	0.81	0.91	0.3	0.85	-0.92	0.44	0.04	0.48	0.99		0.92	0.34	0.87	0.57	0.91	0.62	0.81	0.91	0.91	0.43	-0.08
Long Term Debt	0.65	0.93	0.91	0.48	-0.22	0.96	0.94	0.36	0.79	-0.96	0.6	0.12	0.64	0.92	0.92		0.46	0.93	0.69	0.91	0.81	0.89	0.91	0.94	0.55	-0.15
Cash And Short Term Investments	0.92	0.37	0.42	0.1	0.72	0.54	0.53	0.66	-0.07	-0.61	0.64	0.85	0.63	0.36	0.34	0.46		0.68	0.67	0.28	0.58	0.78	0.27	0.53	0.99	-0.44
Common Stock Shares Outstanding	0.81	0.88	0.89	0.45	0.05	0.91	0.96	0.57	0.62	-0.99	0.75	0.38	0.72	0.86	0.87	0.93	0.68		0.73	0.82	0.87	0.99	0.82	0.96	0.75	-0.24
Short Term Investments	0.74	0.56	0.62	0.35	0.24	0.68	0.63	0.55	0.43	-0.72	0.47	0.17	0.63	0.62	0.57	0.69	0.67	0.73		0.51	0.52	0.76	0.51	0.63	0.71	-0.24
Non Current Liabilities Total	0.55	0.98	0.94	0.54	-0.43	0.89	0.9	0.14	0.9	-0.88	0.46	0.01	0.68	0.92	0.91	0.91	0.28	0.82	0.51		0.72	0.76	0.99	0.9	0.37	-0.03
Other Current Assets	0.77	0.75	0.76	0.45	0.1	0.89	0.85	0.51	0.5	-0.84	0.85	0.39	0.8	0.61	0.62	0.81	0.58	0.87	0.52	0.72		0.85	0.73	0.85	0.63	-0.16
Other Stockholder Equity	0.86	0.82	0.83	0.39	0.18	0.89	0.92	0.64	0.52	-0.96	0.75	0.49	0.72	0.81	0.81	0.89	0.78	0.99	0.76	0.76	0.85		0.75	0.92	0.83	-0.3
Total Liab	0.54	0.98	0.95	0.63	-0.45	0.88	0.9	0.17	0.91	-0.88	0.48	-0.01	0.68	0.92	0.91	0.91	0.27	0.82	0.51	0.99	0.73	0.75		0.9	0.36	0.07
Property Plant And Equipment Gross	0.71	0.93	0.94	0.49	-0.13	0.91	1.0	0.39	0.73	-0.97	0.65	0.26	0.7	0.9	0.91	0.94	0.53	0.96	0.63	0.9	0.85	0.92	0.9		0.61	-0.17
Total Current Assets	0.94	0.45	0.49	0.18	0.64	0.62	0.61	0.69	0.03	-0.69	0.7	0.8	0.66	0.45	0.43	0.55	0.99	0.75	0.71	0.37	0.63	0.83	0.36	0.61		-0.43
Short Term Debt	-0.34	0.01	0.04	0.7	-0.46	-0.19	-0.17	-0.12	0.21	0.17	-0.19	-0.42	-0.14	-0.08	-0.08	-0.15	-0.44	-0.24	-0.24	-0.03	-0.16	-0.3	0.07	-0.17	-0.43

Click cells to compare fundamentals

Revance Account Relationship Matchups

Revance fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	340.3M	720.2M	531.2M	581.9M	478.5M	331.9M
Other Current Liab	21.6M	31.6M	37.8M	54.4M	53.8M	56.5M
Total Current Liabilities	41.0M	61.0M	67.3M	75.7M	89.2M	51.0M
Total Stockholder Equity	225.5M	374.3M	68.5M	12.6M	(151.6M)	(144.0M)
Other Liab	47.9M	77.3M	75.6M	80.1M	92.1M	96.7M
Property Plant And Equipment Net	41.3M	47.1M	69.0M	67.8M	90.2M	94.7M
Current Deferred Revenue	7.9M	7.9M	9.4M	6.9M	10.7M	7.6M
Net Debt	(141.8M)	(121.4M)	213.9M	309.5M	340.6M	357.6M
Retained Earnings	(844.2M)	(1.1B)	(1.4B)	(1.8B)	(2.1B)	(2.0B)
Accounts Payable	8.0M	12.7M	10.6M	4.5M	13.8M	7.0M
Cash	171.2M	333.6M	110.6M	109.0M	137.9M	143.2M
Non Current Assets Total	43.7M	270.2M	285.0M	207.2M	139.6M	90.0M
Non Currrent Assets Other	1.7M	4.8M	13.7M	35.2M	32.7M	34.3M
Other Assets	2.4M	4.8M	13.7M	35.2M	40.5M	42.6M
Cash And Short Term Investments	290.1M	436.5M	225.1M	340.7M	253.9M	224.4M
Common Stock Shares Outstanding	43.5M	58.0M	67.5M	72.7M	84.6M	88.8M
Short Term Investments	119.0M	102.9M	114.4M	231.7M	116.6M	81.3M
Liabilities And Stockholders Equity	340.3M	720.2M	531.2M	581.9M	478.5M	331.9M
Non Current Liabilities Total	73.8M	285.0M	395.4M	493.6M	540.8M	567.9M
Other Current Assets	6.5M	11.6M	15.1M	4.4M	11.7M	12.3M
Other Stockholder Equity	1.1B	1.5B	1.5B	1.8B	1.9B	2.0B
Total Liab	114.8M	345.9M	462.7M	569.3M	630.1M	661.6M
Property Plant And Equipment Gross	41.3M	47.1M	69.0M	67.8M	90.2M	94.7M
Total Current Assets	296.6M	450.0M	246.1M	374.7M	338.9M	241.9M
Accumulated Other Comprehensive Income	(8K)	3K	(18K)	(374K)	14K	14.7K
Short Term Debt	3.5M	8.9M	9.5M	9.8M	10.9M	11.8M
Property Plant Equipment	14.8M	17.5M	69.0M	67.8M	77.9M	81.8M
Common Stock	52K	69K	72K	82K	88K	83.6K
Net Tangible Assets	225.5M	156.0M	(133.8M)	(91.6M)	(82.4M)	(78.3M)
Retained Earnings Total Equity	(684.8M)	(844.2M)	(1.1B)	(1.4B)	(1.3B)	(1.2B)
Capital Surpluse	830.4M	1.1B	1.5B	1.5B	1.7B	1.0B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

When determining whether Revance offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Revance's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Revance Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Revance Stock:

How To Invest In Revance

Details

Is Revance Stock a good investment?

Details

What is Revance's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Revance. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For information on how to trade Revance Stock refer to our How to Trade Revance Stock guide.

You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Revance. If investors know Revance will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Revance listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(3.34)

Revenue Per Share

2.656

Quarterly Revenue Growth

0.107

Return On Assets

(0.24)

Return On Equity

(20.97)

The market value of Revance is measured differently than its book value, which is the value of Revance that is recorded on the company's balance sheet. Investors also form their own opinion of Revance's value that differs from its market value or its book value, called intrinsic value, which is Revance's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Revance's market value can be influenced by many factors that don't directly affect Revance's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Revance's value and its price as these two are different measures arrived at by different means. Investors typically determine if Revance is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Revance's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Revance Research Development vs Ebitda Analysis

Research Development vs Ebitda

Research Development vs Ebitda Correlation Analysis

Correlation Coefficient

Research Development

Ebitda

Revance fundamental ratios Correlations

Revance Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Revance fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Other Assets	+ 0.99	Non Currrent Assets Other
Total Current Assets	+ 0.99	Cash And Short Term Investments
Other Stockholder Equity	+ 0.99	Common Stock Shares Outstanding
Total Liab	+ 0.99	Non Current Liabilities Total
Non Current Liabilities Total	+ 0.98	Short Long Term Debt Total

Common Stock Shares Outstanding	- 0.99	Retained Earnings
Property Plant And Equipment Gross	- 0.97	Retained Earnings
Retained Earnings	- 0.97	Property Plant And Equipment Net
Other Stockholder Equity	- 0.96	Retained Earnings
Long Term Debt	- 0.96	Retained Earnings
Retained Earnings	- 0.93	Other Liab